FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

32615311000001104: Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-May 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
99497301000001113 Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
99497401000001117 Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Is a Calcipotriol 50micrograms/g / Betamethasone dipropionate 500micrograms/g foam true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has active ingredient Betamethasone true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has active ingredient Calcipotriol true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has specific active ingredient Betamethasone dipropionate true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has specific active ingredient Calcipotriol monohydrate false Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has dispensed dose form Foam true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Is a Enstilar true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has manufactured dose form Foam false Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has specific active ingredient Calcipotriol monohydrate true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has basis of strength substance Calcipotriol true Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) 60 gram Has AMP True Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Inferred relationship Existential restriction modifier
Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) 120 gram 2 x 60g Has AMP True Enstilar 50micrograms/g / 0.5 mg/g cutaneous foam (LEO Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start